(Q34402406)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20581169%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20581169%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

main subject

arterial hypertension

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20581169%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Marius M Hoeper

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20581169%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Horst Olschewski

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20581169%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Friedrich Grimminger

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20581169%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

6

Robyn J Barst

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20581169%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Nicholas W Morrell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20581169%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Andrew J Peacock

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20581169%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Shelley Shapiro

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20581169%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Heiko Golpon

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20581169%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Mark Toshner

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20581169%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Steve Pascoe

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20581169%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

English

0 references

publication date

25 June 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20581169%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Respiratory and Critical Care Medicine

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20581169%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

182

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20581169%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20581169%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

1171-1177

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20581169%20AND%20SRC:MED&resulttype=core&format=json

Updated evidence-based treatment algorithm in pulmonary arterial hypertension.

6 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001259

Diagnosis and assessment of pulmonary arterial hypertension.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001259

Cellular and molecular basis of pulmonary arterial hypertension

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001259

A meta-analysis of randomized controlled trials in pulmonary arterial hypertension

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001259

Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001259

Uncertainties in the diagnosis and treatment of pulmonary arterial hypertension.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001259

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001259

Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001259

Flying under the radar: the new wave of BCR-ABL inhibitors

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001259

A meta-analysis of trials of pulmonary hypertension: a clinical condition looking for drugs and research methodology

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001259

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001259

Cardiotoxicity of the cancer therapeutic agent imatinib mesylate.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001259

Sildenafil citrate therapy for pulmonary arterial hypertension

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001259

Reversal of experimental pulmonary hypertension by PDGF inhibition

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001259

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001259

Mechanism of action and in vivo role of platelet-derived growth factor

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001259

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001259

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001259

Tadalafil therapy for pulmonary arterial hypertension.

6 July 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0123OC

Alterations in Ca2+ cycling by lysoplasmenylcholine in adult rabbit ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0123OC

Imatinib for the treatment of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0123OC

Long term imatinib treatment in pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0123OC

Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0123OC

Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001259

Imatinib Mesylate in the Treatment of Refractory Idiopathic Pulmonary Arterial Hypertension

27 October 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0123OC

Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension

21 January 2018

1 reference

12 December 2020

In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'

1 reference

12 December 2020

Bosentan therapy for pulmonary arterial hypertension

1 reference

12 December 2020

Role of platelet-derived growth factor in vascular remodeling during pulmonary hypertension in the ovine fetus

1 reference

12 December 2020

Mild hypoxia impairs alveolarization in the endothelial nitric oxide synthase-deficient mouse

1 reference

12 December 2020

10.1164/RCCM.201001-0123OC

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20581169%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20581169%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

PubMed publication ID

20581169

1 reference